These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38391976)
1. In Vitro Glioblastoma Model on a Plate for Localized Drug Release Study from a 3D-Printed Drug-Eluted Hydrogel Mesh. Chehri B; Liu K; Vaseghi G; Seyfoori A; Akbari M Cells; 2024 Feb; 13(4):. PubMed ID: 38391976 [TBL] [Abstract][Full Text] [Related]
2. A 3D bioprinted hydrogel mesh loaded with all-trans retinoic acid for treatment of glioblastoma. Mirani B; Pagan E; Shojaei S; Duchscherer J; Toyota BD; Ghavami S; Akbari M Eur J Pharmacol; 2019 Jul; 854():201-212. PubMed ID: 30974104 [TBL] [Abstract][Full Text] [Related]
3. A biopolymeric mesh enriched with PLGA microparticles loaded with AT101 for localized glioblastoma treatment. Hellmold D; Arnaldi P; Synowitz M; Held-Feindt J; Akbari M Biomed Mater; 2023 Apr; 18(3):. PubMed ID: 37054732 [TBL] [Abstract][Full Text] [Related]
4. Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma. Rodriguez de Anda DA; Ohannesian N; Martirosyan KS; Chew SA J Biomed Mater Res B Appl Biomater; 2019 Oct; 107(7):2317-2324. PubMed ID: 30767394 [TBL] [Abstract][Full Text] [Related]
5. Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle. Yang TC; Liu SJ; Lo WL; Chen SM; Tang YL; Tseng YY Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074038 [TBL] [Abstract][Full Text] [Related]
6. Curcumin combining temozolomide formed localized nanogel for inhibition of postsurgical chemoresistant glioblastoma. Liang Q; Zhuo Y; Wu X; Zheng S; Zhuang J; Wang K; Chen S Nanomedicine (Lond); 2023 May; 18(12):907-921. PubMed ID: 37466022 [TBL] [Abstract][Full Text] [Related]
7. Nanocomposite formulation for a sustained release of free drug and drug-loaded responsive nanoparticles: an approach for a local therapy of glioblastoma multiforme. Erthal LCS; Shi Y; Sweeney KJ; Gobbo OL; Ruiz-Hernandez E Sci Rep; 2023 Mar; 13(1):5094. PubMed ID: 36991081 [TBL] [Abstract][Full Text] [Related]
8. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma. Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679 [TBL] [Abstract][Full Text] [Related]
10. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival. Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818 [TBL] [Abstract][Full Text] [Related]
11. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic- Banstola A; Duwa R; Emami F; Jeong JH; Yook S Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558 [TBL] [Abstract][Full Text] [Related]
12. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection. Zhao M; Bozzato E; Joudiou N; Ghiassinejad S; Danhier F; Gallez B; Préat V J Control Release; 2019 Sep; 309():72-81. PubMed ID: 31306678 [TBL] [Abstract][Full Text] [Related]
13. 3D-printed implants loaded with acriflavine for glioblastoma treatment. Korelidou A; Domínguez-Robles J; Islam R; Donnelly RF; Coulter JA; Larrañeta E Int J Pharm; 2024 Nov; 665():124710. PubMed ID: 39277153 [TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment. Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532 [TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic. Chu W; Houston ZH; Fletcher NL; Huda P; Ahamed M; Lim TX; Day BW; Pinkham M; Thurecht KJ Biomacromolecules; 2023 Jun; 24(6):2674-2690. PubMed ID: 37143361 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer. Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703 [TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of temozolomide by nanocarriers based on folic acid-hollow TiO Uribe-Robles M; Ortiz-Islas E; Rodriguez-Perez E; Valverde FF; Lim T; Martinez-Morales AA Biomater Adv; 2023 Aug; 151():213442. PubMed ID: 37207587 [TBL] [Abstract][Full Text] [Related]
18. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures. Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716 [TBL] [Abstract][Full Text] [Related]
19. Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide: Sahoo RK; Kumar H; Jain V; Sinha S; Ajazuddin ; Gupta U ACS Biomater Sci Eng; 2023 Jul; 9(7):4288-4301. PubMed ID: 37307155 [TBL] [Abstract][Full Text] [Related]
20. Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy. Kadhim ZA; Sulaiman GM; Al-Shammari AM; Khan RA; Al Rugaie O; Mohammed HA Molecules; 2022 Sep; 27(18):. PubMed ID: 36144488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]